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A B S T R A C T
BACkgRound: Cardiac magnetic resonance imaging (MRI) has been established in 
clinical practice as a valid imaging modality for the diagnosis of various cardiovascu-
lar disorders.
oBjeCTiveS: To underline the importance of cardiac MRI as an alternative non - 
invasive imaging method for the diagnosis and follow-up of cardiac patients based on 
findings from our own recent experience.
PATienTS And MeThodS: The study included all cardiac patients referred for cardiac 
MRI over a period of one year. Cardiac MRI studies were performed with the use of a 
1.5-Tesla scanner using a body phased-array coil, breath and ECG-triggering. Almost 
all cardiac sequences were gated to the patient’s cardiac cycle. Cine imaging for the 
evaluation of cardiac volumes and heart motion was performed using a cine breath-
hold true short-axis and true four-chamber sequence with whole left ventricular cov-
erage. Black blood imaging for the assessment of morphology was acquired on a true 
short-axis and true four-chamber view. Depending on the pathology under investiga-
tion, special sequences were added to the imaging protocol, such as late-enhancement 
imaging after gadolinium administration.
ReSulTS: The study cohort comprised 114 patients who were referred for cardiac 
MRI with the following indications and clinical diagnoses: myocarditis (n=29), ar-
rhythmogenic right ventricular cardiomyopathy (ARVC; n=27), valvular heart dis-
ease (n=23), history of myocardial infarction (n=13; seeking myocardial viability), 
hypertrophic (n=12), or dilated (n=2), or tako-tsubo (n=1), or non-compaction (n=2) 
cardiomyopathy, pericardial effusion (n=2) and various intracardiac masses (n=3). 
Cardiac MRI confirmed the clinical diagnosis and gave further specific information 
in 52% of myocarditis cases, in 37% of suspected ARVC cases, in 38% of coronary 
artery disease patients regarding myocardial viability, while it confirmed all other 
clinical diagnoses (100% match).
ConCluSionS: Cardiac MRI represents a clinically useful imaging method for the 
diagnosis of various cardiac disorders since it has the capability of providing highly 
accurate and reproducible measurements of cardiac hemodynamics in addition to the 
detailed demonstration of cardiac anatomical structures.
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i n T R o d u C T i o n
Cardiac magnetic resonance imaging (MRI) has been es-
tablished in clinical practice for the diagnosis and management 
of cardiovascular diseases. It is a rather safe examination since 
no long-term ill effects have been reported.¹
Considerable technical advances, in both hardware and 
software, have been achieved over the recent years and many 
techniques are currently available for performing cardiac 
MRI. This imaging modality was introduced into clinical rou-
tine for the assessment of cardiac morphology more than 10 
years ago. The multiplanar cross-sectional nature inherent to 
cine-MRI, coupled with high spatial and temporal resolution, 
has been shown to provide highly accurate and reproducible 
measurements of cardiac hemodynamic parameters in both 
acquired and congenital heart diseases. Indeed, it has been 
considered as the most precise technique for the quantifica-
tion of ventricular volumes, function and mass, representing 
this way a standard of reference method for the assessment 
of the ejection fraction of both ventricles and of regional wall 
motion abnormalities.2-4
Cardiac MRI is also the optimal method to assess thera-
peutic response with regards to geometrical and dynamic 
ventricular parameters.³,4 Moreover, delayed contrast enhance-
ment is an accurate and robust method used in the diagnosis of 
ischemic and non-ischemic cardiomyopathies (CM) and of less 
common diseases, such as cardiac sarcoidosis and myocardi-
tis.5,6 Finally, first-pass magnetic contrast myocardial perfusion 
is becoming an alternative to radionuclide techniques for the 
detection of coronary artery disease (CAD) and/or assessment 
of myocardial viability. In this article we present our experi-
ence with cardiac MRI in patients with various cardiovascular 
diseases referred to us during the past 12 months.
P A T i e n T S  A n d  M e T h o d S
The study included all cardiac patients referred over a 
period of one year for cardiac MRI. Cardiac MRI studies 
were performed with a 1.5-Tesla scanner (Signa Excite, GE 
Healthcare) using a body phased-array coil, breath and ECG-
triggering. Various measures were taken before or during 
image acquisition. At first, patients were informed about the 
procedure and the importance of breath holding during the 
examination was underlined to them. Image acquisition at end-
expiration was preferred since it is highly reproducible. Almost 
all cardiac sequences were gated to the patient’s cardiac cycle; 
to accomplish gating, electrocardiographic leads were applied 
and the electrocardiographic waveform was evaluated before 
image acquisition begins. Since the placement of surface 
coils in relation to the heart is crucial to achieve a good 
signal-to-noise ratio, the centers of both the anterior and 
the posterior surface coils were then well aligned with the 
center of the heart. After the patient was positioned within 
the magnet, multiplanar scout images were obtained and 
reviewed to ensure that the surface coils were properly 
placed over the heart and that the patient was positioned 
so that the heart was at or near the magnet isocenter.
After the initial gradient echo had been localized in 
the three orthogonal planes, the following sequences were 
acquired: vector cardiogram triggered balanced Fiesta in 
single-slice, multiphase mode in the long axis, pseudo-short 
axis and four-chamber plane. Cine imaging for the evaluation 
of cardiac volumes and heart motion was performed using 
a cine breath-hold true short-axis and true four-chamber 
sequence with whole left ventricular coverage (axial SSFP 
bright blood cine Image -FIESTA, true 4-chamber-view cine 
images, and true short-axis cine images; cover the entire left 
ventricle; TR = 3.5 msec; TE = minimum, flip angle = 45–70°, 
slice thickness = 8 mm, interslice gap = 2 mm, FOV = 36–40 
cm, 16–20 views per segment). Black blood imaging for the 
assessment of morphology was acquired on a true short-axis 
and true four-chamber view (axial black blood images: double 
inversion recovery TSE/FSE starting from the diaphragm to 
the pulmonary artery, TR = 2 R-R intervals, TE = 5 msec GE; 
slice thickness = 5 mm Interslice gap = 5 mm FOV = 28 cm). 
Black blood Images with fat suppression on a true short-axis 
and true four-chamber view were also obtained. Cardiac trig-
gered, flow sensitive phase-contrast gradient echo sequences 
were obtained at levels perpendicular to the long axis of the 
ascending aorta and the main pulmonary artery. Depending 
on the pathology under investigation special sequences were 
added to the imaging protocol, such as late-enhancement im-
aging in a short-axis inversion-recovery sequence performed 
10 and 15 min after gadolinium administration (TI scout 
4-chamber view, using TI scout sequences or trial TI times to 
suppress normal myocardium; delayed gadolinium short axis 
images 10–15 min delay; same slice coverage as short axis cine 
images, TI : 250-270, flip angle = 20–25°, slice thickness = 8 
mm, interslice gap = 2 mm, FOV = 36–40 cm).
In order to study regional myocardial contraction, tagging 
sequence was used, which superimposes a grid of dark lines 
across the image in diastole. These tags subsequently deform 
through the cardiac cycle allowing the calculation of regional 
myocardial strain. Cardiac magnetic resonance angiography 
was performed with three-dimensional (3D) coverage of the 
vessel during a short breath-hold and after intravenous injec-
tion of a gadolinium-based contrast agent. In some cases 
non-contrast magnetic resonance angiographic techniques 
were also used.
Image analysis was performed on a workstation (report-
card GE) using the cardiac analysis package. Evaluation 
included biventricular mass, dimensions and end-diastolic, 
end-systolic volumes, ejection fraction and stroke volume 
as well as aorta and pulmonary artery flow measurements. 
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Left ventricular and right ventricular end-diastolic volumes, 
end-systolic volumes, ejection fractions, and stroke volumes 
were calculated throughout the cardiac cycle by defining the 
endocardial and epicardial borders at end-diastole and end-
systole in the short-axis FIESTA images and evaluated with a 
computer aided analysis package for planimetry.
Flow and volume measurements in the pulmonary artery 
and aorta and their ratio were obtained throughout the cardiac 
cycle by manually tracing the respective vessel contours on the 
phase images from the phase contrast gradient echo sequences. 
All volume and flow values were indexed to body surface area. 
The evaluation of biventricular mass was achieved by determi-
nation of the epicardial and endocardial contour of the free 
wall on the same set of end-diastolic short-axis images. The 
obtained volume was multiplied by 1.05 g/cc. Papillary muscles 
and trabeculae were included in the mass measurement and 
excluded from the volume analysis.
R e S u l T S
One-hundred fourteen patients were examined in the MRI 
unit of our Radiology department over the last one year (Table 
1). Twenty-nine patients were referred with symptoms sugges-
tive of myocarditis, 27 with ventricular arrhythmias suggestive 
of arrhythmogenic right ventricular cardiomyopathy (ARVC), 
23 with valvular heart disease to assess the severity of valvular 
regurgitation, 13 with coronary artery disease (history of myo-
cardial infarction) to detect viable myocardial tissue, 12 with 
hypertrophic cardiomyopathy (CM) to assess left ventricular 
outflow tract gradient, 2 with dilated CM to measure left 
ventricular ejection fraction, two with non-compaction CM, 
one with Tako-Tsubo CM, 2 with pericardial effusion, and 3 
with various intracardiac masses.
In 15 out of the 29 patients (51.7%) with possible myo-
carditis the diagnosis was established based on the finding of 
late enhanced images (Fig. 1). Of the 27 patients with ven-
tricular arrhythmias and suspected ARVC, evidence strongly 
indicating the presence of ARVC (localized aneurysms, right 
ventricular dilation with low ejection fraction, late enhance-
ment images positive for fibrosis) was documented in 10 of 
them (37%). In the 23 patients with valvular heart disease, an 
accurate estimate of the severity of regurgitation was achieved 
in all of them. Moreover, viable myocardium was detected 
in 5 out of the 13 (38.4%) patients with CAD examined. An 
accurate measurement of the pressure gradient in the left 
ventricular outflow tract was achieved in all patients with hy-
pertrophic CM referred for cardiac MRI (Fig. 2). In addition, 
TABle 1. Patients in whom a Cardiac MRI was Performed 
and Respective Diagnoses
Cardiac disease
Referral 
diagnosis
Final diagnosis 
(no./ %)
Myocarditis 29 15 (51.7%)
ARVC 27 10 (37%)
Valvular heart disease 23 23
CAD (myocardial viability) 13 5 (38.4%)
Hypertrophic CM 12 12
Idiopathic dilated CM 2 2
Non-compaction CM 2 2
Tako-Tsubo CM 1 1
Pericardial disease 2 2 
Intracardiac masses 3 3
Total 114 75
ARVC= arrhythmogenic right ventricular cardiomyopathy; CAD= 
coronary artery disease; CM= cardiomyopathy; MRI= magnetic reso-
nance imaging
FiguRe 1. Acute Myocarditis. Delayed enhancement imaging, 
short-axis view, 5 minutes after intravenous Gadolinium infu-
sion. Gadolinium enhancement in the lower part of the left ven-
tricle (arrow).
FiguRe 2. Hypertrophic cardiomyopathy. Double-IR sequence 
(left), FIESTA cine-sequence (right).
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left ventricular ejection fraction was accurately measured in 
the 2 patients with dilated CM. Finally, fine anatomic details 
of their underlying pathology were delineated in the rest of 
the patients (Fig. 3), while in the 2 patients with pericardial 
effusion cardiac MRI excluded the diagnosis of tuberculous 
pericarditis based on the absence of gadolinium enhancement 
as well as on the lack of both pericardial anomalous thickening 
and of nodules suggestive of tuberculomas.
d i S C u S S i o n
We herein presented out experience in 114 patients with 
the use of cardiac MRI during the time span of one year. Our 
findings strongly support the important role of this relatively 
new imaging technique in the diagnosis of various cardiovas-
cular disorders. Indeed, recent technologic advances have al-
lowed cardiac MRI to enter the mainstream imaging practice 
for many disease entities. The development of increasing 
magnet strengths and surface coil channels, rapid k-space 
sampling and post-processing techniques and sophisticated 
myocardial soft-tissue characterization sequences have made 
cardiac MRI a powerful tool in the workup of many complex 
cardiac conditions. The clinical use of this imaging technique 
continues to expand because of the increasing experience 
and proliferation of cardiac MRI centers. As the worldwide 
prevalence of cardiovascular disease continues to rise, the use 
of cardiac MR imaging provides an opportunity for improved 
and cost-effective noninvasive cardiac assessment. Continued 
progress in cardiac MRI technology promises to further widen 
its clinical application in the diagnosis and management of 
diseases of the cardiovascular system.
The most important current clinical applications of this 
imaging technique are detailed below. Evaluation of patients 
with congenital heart disease (CHD) is a significant strength of 
cardiac MRI because 3-dimensional contiguous data sets are 
very effective for the complete depiction of the pathological 
anatomy of both simple and complex CHD (Fig. 4). Moreover, 
the lack of ionizing radiation is an important consideration 
when performing sequential studies in children and young 
adults. Thus, cardiac MRI is usually performed following, and 
as an adjunct to, transthoracic echocardiography in neonates 
and infants. In contrast, it becomes the first-line technique 
in older children, in adolescents or adults, in diseases with 
complex anatomy and at any age after surgery because the 
body habitus as well as the interposition of scar tissue and 
lungs become an increasing problem for transthoracic echo-
cardiography.7
Cardiac MRI is well established for the evaluation of a 
wide variety of acquired vascular diseases. It is particularly 
useful for vascular lumen imaging with its ability to generate 
projection angiograms. In addition to morphologic imaging 
of blood vessels, velocity mapping can be used to assess and 
measure the blood flow.1 It is well suited for use in patients 
with contraindications to X-ray contrast.
Cardiac MRI has opened new avenues for assessing coro-
nary artery disease (CAD) and its consequences. It provides 
valuable information which may not be available from other di-
agnostic tools such as echocardiography and nuclear cardiology 
currently dominating non-invasive diagnosis in patients with 
CAD. Its superb spatial and temporal resolution combined 
with excellent soft tissue contrast allow for accurate assessment 
of cardiac morphology, global cardiac function, regional wall 
motion, and the extent of myocardial infarction (Fig. 5). 5,8
FiguRe 4. Atrial septal defect with left to right shunt (arrow) 
(four chamber view; cine).
FiguRe 3. Non-compaction cardiomyopathy (arrows) (four-
chamber view; cine).
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The cardiomyopathies include a variety of diseases where 
the primary pathology directly involves the myocardium ex-
cluding CAD. Cardiac MRI is proving increasingly valuable 
in the identification and management in these conditions.5,8 
As shown in the present series, a particularly difficult to 
diagnose CM with use of echocardiography is the ARVC, 
in which cardiac MRI has immensely contributed and has 
helped arrhythmologists to properly manage these patients; 
in 10 out of 27 (37%) patients in our cohort suspected of 
having been afflicted by ARVC, cardiac MRI confirmed the 
diagnosis. Cardiac MRI was also very helpful in other rare 
types of CM, such as the non-compaction (n=2) and tako-
tsubo (n=1) variety. Another type of myocardial disease is 
the case of myocarditis, in which again cardiac MRI has the 
potential to assist in the diagnosis. This can be accomplished 
by its tissue characterization capabilities9 with the early and 
delayed gadolinium enhancement with its subepicaridal, as 
opposed to subendocardial (seen in CAD) distribution; this 
was achieved in ~52% of our own cases referred for cardiac 
MRI with a potential diagnosis of myocarditis.
Cardiac MRI is a valuable tool for individual follow-up 
of the severity of regurgitant lesions and for quantification of 
the effects of valvular lesions on ventricular volumes, function 
and myocardial mass. Cardiac MRI may play a complemen-
tary role when transthoracic acoustic windows are poor and 
a transesophageal approach is undesirable, or when results 
of echocardiography and catheterization are conflicting.10-12
Cardiac MRI is particularly helpful in patients with cardiac 
masses determining the relationship to normal intracardiac 
structures and the tumour extension to adjacent vascular and 
mediastinal structures, infiltration into the pericardium, and 
surgical planning. In addition several other MRI features can 
assist in tumour characterization.13
Both cardiac MRI and computed tomography (CT) are 
well suited to define anatomic abnormalities of the pericar-
dium including pericardial thickening and effusions. Cardiac 
MRI has the advantage of being able to depict and quantify 
the functional abnormalities which may be associated with 
pericardial disease. The large field of view of CT and MRI is 
helpful in providing a better overview of the extent of pericar-
dial disease, and to define the relationship with surrounding 
anatomic structures. For suspected pericardial thickening, 
MRI and CT are primary imaging modalities, with CT having 
an advantage for identification of pericardial calcium.1,4,8,14
C o n C l u S i o n
Recent technological advances have led cardiac MRI to 
enter the practice of mainstream cardiac imaging. Cardiac 
MIR is currently used in clinical practice for the evaluation of 
congenital heart disease, of the aorta, of cardiac tumors, of the 
pericardium, of cardiomyopathies, of valvular heart disease, of 
CAD, and for the assessment of ventricular function and mass. 
We underlined the importance of cardiac MRI as an alterna-
tive non-invasive imaging method for diagnosis and follow-up 
of 114 patients with various cardiovascular disorders, based 
on data from our own recent experience with this modern 
technique over the period of one year.
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